Table of Contents
What changed
FY23 swung to positive across every disclosed profit line after a deeply negative FY22. "Revenue" — which for this vehicle captures investment income and fair-value movements rather than trading sales — moved from -$32.6m to +$43.6m, a $76.2m swing. NPAT moved correspondingly from -$34.6m to +$38.3m, a $73.0m swing and a 210.6% change off a negative base. PBT, proxied to profit from continuing operations at $38.3m, grew 209.1% on the same basis. The final dividend was lifted modestly to 1.44 cents per share from 1.36 cents, a 5.9% increase. Operating cash flow, period-end cash, total assets, liabilities, and equity were not disclosed in the supplied FY23 extraction; FY22 comparators were cash of $2.6m, total assets of $172.3m, and equity of $170.7m.
What matters
- The result is a portfolio-return reversal, not operating growth. Both the prior and current "revenue" lines are net of fair-value movements, so the 233.6% headline change reflects market conditions rather than a structural step-up in recurring income. Read durability accordingly.
- Capital return moved up only marginally. Despite a $73m NPAT swing, the declared final dividend rose just 0.08cps. That is consistent with a listed-investment-vehicle payout framework rather than earnings-linked distribution, and it implicitly signals that management is not treating FY23's mark-to-market gains as distributable income.
- Balance-sheet transparency in the supplied release is thin. Period-end cash, NAV, and total assets for FY23 are absent from the extraction, which matters disproportionately for a vehicle where NAV is the primary operating metric.
Expectations
No formal targets, guidance, or forward-work disclosures were supplied. Against the HY23 interim, the full year shows materially second-half-weighted contribution: HY23 revenue of $15.2m was 35.0% of the $43.6m full-year figure, and HY23 NPAT of $12.2m was 31.9% of the $38.3m full-year figure. The implied second-half revenue of $28.3m and second-half NPAT of $26.1m indicate that roughly two-thirds of the reported gain was booked in H2. For a mark-to-market vehicle, this is a statement about market direction in the back half of the period rather than operating momentum, and should not be extrapolated.
Quality of result
The earnings reversal looks overwhelmingly valuation-driven rather than cash-generative. The prior year's tax benefit was only 1.4% of PBT, so tax effects do not explain the swing; the cleaner PBT growth read (209.1%) is effectively identical to the NPAT read (210.6%). However, operating cash flow for FY23 is not disclosed in the supplied data, so cash conversion against the $38.3m NPAT cannot be tested. Given the prior year ran -$18.0m in operating cash outflow against a -$34.6m loss, the FY23 OCF disclosure — when available — is the critical test of how much of the reported profit is realised versus unrealised fair-value gain. On the evidence supplied, treat the result as low-durability until that reconciliation is visible.
Unresolved
- What is the FY23 period-end NAV per share, cash balance, and total assets, and how do they reconcile to the prior year's $170.7m equity base?
- What share of the $43.6m revenue figure is realised gains and dividend income versus unrealised fair-value movement?
- What is FY23 operating cash flow, and does it support the lifted dividend without drawing on capital?
- Is the 1.44cps a final-only declaration or the full-year total, and how does it compare to the vehicle's stated distribution policy?
This briefing cannot assess NAV performance, discount/premium to NAV, portfolio composition, realised-versus-unrealised income split, or management/performance fee impact, because none of those disclosures were present in the supplied extraction.
Key metrics
| Metric | FY23 | FY22 | Change |
|---|---|---|---|
| Revenue | $43.6m | −$32.6m | +233.6% ↑ |
| Net profit after tax | $38.3m | −$34.6m | +210.6% ↑ |
| Net cash inflow from operating activities | — | −$18.0m | — |
| Final dividend per share | 1.4c | 1.4c | +5.9% ↑ |
| Total assets | $0.0m | $172.3m | -100.0% ↓ |
Reference: annolyse.ai/briefings/brm-fy23
Analytical metrics
| Metric | FY23 | FY22 | Context |
|---|---|---|---|
| HY23 share of FY23 revenue | 35.0% | — | Other half was 65.0% |
| HY23 share of FY23 NPAT | 31.9% | — | Other half was 68.1% |
| Profit from continuing operations | $38.3m | −$34.6m | +$73.0m |
Reference: annolyse.ai/briefings/brm-fy23
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.